Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 0 | 3,000 | 0 | 7,000 | 0 |
Gross Profit | N/A | 3,000 | N/A | 7,000 | N/A |
Operating Expenses | 15,757 | 10,151 | 9,087 | 9,555 | 9,988 |
Operating Income | -15,757 | -7,151 | -9,087 | -2,555 | -9,988 |
Interest Expense | 451 | 456 | 452 | 439 | 428 |
Other Income | 1,122 | 746 | 449 | 310 | -1,019 |
Pre-tax Income | -15,086 | -6,861 | -9,090 | -2,684 | -11,435 |
Net Income Continuous | -15,086 | -6,861 | -9,090 | -2,684 | -11,435 |
Net Income | $-15,086 | $-6,861 | $-9,090 | $-2,684 | $-11,435 |
EPS Basic Total Ops | -0.63 | -0.19 | -0.45 | -0.13 | -0.75 |
EPS Basic Continuous Ops | -0.63 | -0.19 | -0.45 | -0.13 | -0.75 |
EPS Diluted Total Ops | -0.63 | -0.19 | -0.45 | -0.13 | -0.75 |
EPS Diluted Continuous Ops | -0.63 | -0.19 | -0.45 | -0.13 | -0.75 |
EBITDA(a) | $-15,703 | $-7,104 | $-9,041 | $-2,504 | $-9,949 |